Structure-Based Discovery of Novel Nonpeptide Inhibitors Targeting SARS-CoV-2 Mpro
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure-Based Discovery of Novel Nonpeptide Inhibitors Targeting SARS-CoV-2 Mpro
Authors
Keywords
-
Journal
Journal of Chemical Information and Modeling
Volume 61, Issue 8, Pages 3917-3926
Publisher
American Chemical Society (ACS)
Online
2021-07-20
DOI
10.1021/acs.jcim.1c00355
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hyperproduction of 3-hydroxypropionate by Halomonas bluephagenesis
- (2021) Xiao-Ran Jiang et al. Nature Communications
- Computational design and modeling of nanobodies toward SARS‐CoV‐2 receptorbinding domain
- (2021) Jingyi Yang et al. Chemical Biology & Drug Design
- Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening
- (2021) Giorgio Amendola et al. Journal of Chemical Information and Modeling
- A novel coronavirus outbreak of global health concern
- (2020) Chen Wang et al. LANCET
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design
- (2020) Maria Bzówka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- In Silico Exploration of the Molecular Mechanism of Clinically Oriented Drugs for Possibly Inhibiting SARS-CoV-2’s Main Protease
- (2020) Tien Huynh et al. Journal of Physical Chemistry Letters
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
- (2020) Zhenming Jin et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- Discovering small-molecule therapeutics against SARS-CoV-2
- (2020) Vaibhav Tiwari et al. DRUG DISCOVERY TODAY
- Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease
- (2020) Son Tung Ngo et al. Journal of Chemical Information and Modeling
- SARS-CoV-2 Main Protease: A Molecular Dynamics Study
- (2020) Dimas Suárez et al. Journal of Chemical Information and Modeling
- Structure-Based Virtual Screening to Discover Potential Lead Molecules for the SARS-CoV-2 Main Protease
- (2020) Anuj Gahlawat et al. Journal of Chemical Information and Modeling
- MCCS: a novel recognition pattern-based method for fast track discovery of anti-SARS-CoV-2 drugs
- (2020) Zhiwei Feng et al. BRIEFINGS IN BIOINFORMATICS
- Databases for the targeted COVID‐19 therapeutics
- (2020) Yunxia Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors
- (2020) Alicia Jiménez-Alberto et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method
- (2020) Milan Sencanski et al. MOLECULES
- Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs
- (2020) Zhe Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drug binding dynamics of the dimeric SARS-CoV-2 main protease, determined by molecular dynamics simulation
- (2020) Teruhisa S. Komatsu et al. Scientific Reports
- Elucidating the Tight-binding Mechanism of Two Oral Anticoagulants to Factor Xa by Using Induced-fit Docking and Molecular Dynamics Simulation
- (2019) Qingqing Du et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- End-Point Binding Free Energy Calculation with MM/PBSA and MM/GBSA: Strategies and Applications in Drug Design
- (2019) Ercheng Wang et al. CHEMICAL REVIEWS
- Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor
- (2016) Yinglong Miao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
- (2015) Edward Harder et al. Journal of Chemical Theory and Computation
- ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
- (2015) James A. Maier et al. Journal of Chemical Theory and Computation
- From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
- (2014) Rolf Hilgenfeld FEBS Journal
- Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
- (2013) G. Madhavi Sastry et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Structure-Based Design, Synthesis, and Evaluation of Peptide-Mimetic SARS 3CL Protease Inhibitors
- (2011) Kenichi Akaji et al. JOURNAL OF MEDICINAL CHEMISTRY
- Large-Scale Systematic Analysis of 2D Fingerprint Methods and Parameters to Improve Virtual Screening Enrichments
- (2010) Madhavi Sastry et al. Journal of Chemical Information and Modeling
- Discovery of Human Macrophage Migration Inhibitory Factor (MIF)-CD74 Antagonists via Virtual Screening
- (2008) Zoe Cournia et al. JOURNAL OF MEDICINAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started